98 related articles for article (PubMed ID: 24034180)
1. A case of de novo aleukemic mast cell leukemia without c-KIT mutations in exons 8 and 17.
Park SH; Chi HS; Cho YU; Jang S; Park CJ; Lee JH
Int J Lab Hematol; 2014 Aug; 36(4):e44-6. PubMed ID: 24034180
[No Abstract] [Full Text] [Related]
2. De novo leukemic variant of mast cell leukemia with KIT D816V.
Bang HI; Park R; Park ES; Choi IH; Kim KH; Shin JW; Choi TY; Han K; Won JH
Ann Lab Med; 2015 Mar; 35(2):260-2. PubMed ID: 25729733
[No Abstract] [Full Text] [Related]
3. Mast cell leukemia: identification of a new c-Kit mutation, dup(501-502), and response to masitinib, a c-Kit tyrosine kinase inhibitor.
Georgin-Lavialle S; Lhermitte L; Suarez F; Yang Y; Letard S; Hanssens K; Feger F; Renand A; Brouze C; Canioni D; Asnafi V; Chandesris MO; Aouba A; Gineste P; Macintyre E; Mansfield CD; Moussy A; Lepelletier Y; Dubreuil P; Hermine O
Eur J Haematol; 2012 Jul; 89(1):47-52. PubMed ID: 22324351
[TBL] [Abstract][Full Text] [Related]
4. Highly Aggressive de novo Aleukemic Variant of Mast Cell Leukemia Without KIT D816V Mutation.
Suh MC; Ham JY; Park TI; Moon JH; Suh JS
Ann Lab Med; 2017 Nov; 37(6):547-549. PubMed ID: 28840997
[No Abstract] [Full Text] [Related]
5. A case of mast cell leukaemia with exon 9 KIT mutation and good response to imatinib.
Mital A; Piskorz A; Lewandowski K; Wasąg B; Limon J; Hellmann A
Eur J Haematol; 2011 Jun; 86(6):531-5. PubMed ID: 21362052
[TBL] [Abstract][Full Text] [Related]
6. Aleukemic mast cell leukemia with abnormal immunophenotype and c-kit mutation D816V.
Noack F; Sotlar K; Notter M; Thiel E; Valent P; Horny HP
Leuk Lymphoma; 2004 Nov; 45(11):2295-302. PubMed ID: 15512820
[TBL] [Abstract][Full Text] [Related]
7. Mast cell leukemia with novel BRAF variant and concomitant atypical KIT variant.
Chen T; Malysz J; Washburn E; Songdej N; Zhang Y; Bayerl M
Cancer Genet; 2022 Aug; 266-267():33-36. PubMed ID: 35717863
[TBL] [Abstract][Full Text] [Related]
8. The genetic basis of mast cell activation disease - looking through a glass darkly.
Molderings GJ
Crit Rev Oncol Hematol; 2015 Feb; 93(2):75-89. PubMed ID: 25305106
[TBL] [Abstract][Full Text] [Related]
9. Advanced systemic mastocytosis: the impact of KIT mutations in diagnosis, treatment, and progression.
Verstovsek S
Eur J Haematol; 2013 Feb; 90(2):89-98. PubMed ID: 23181448
[TBL] [Abstract][Full Text] [Related]
10. Systemic mastocytosis with associated clonal hematological non-mast-cell lineage disease: analysis of clinicopathologic features and activating c-kit mutations.
Pullarkat VA; Bueso-Ramos C; Lai R; Kroft S; Wilson CS; Pullarkat ST; Bu X; Thein M; Lee M; Brynes RK
Am J Hematol; 2003 May; 73(1):12-7. PubMed ID: 12701114
[TBL] [Abstract][Full Text] [Related]
11. Identification of mutations in the coding sequence of the proto-oncogene c-kit in a human mast cell leukemia cell line causing ligand-independent activation of c-kit product.
Furitsu T; Tsujimura T; Tono T; Ikeda H; Kitayama H; Koshimizu U; Sugahara H; Butterfield JH; Ashman LK; Kanayama Y
J Clin Invest; 1993 Oct; 92(4):1736-44. PubMed ID: 7691885
[TBL] [Abstract][Full Text] [Related]
12. In vivo differentiation of mast cells from acute myeloid leukemia blasts carrying a novel activating ligand-independent C-kit mutation.
Beghini A; Cairoli R; Morra E; Larizza L
Blood Cells Mol Dis; 1998 Jun; 24(2):262-70. PubMed ID: 9714703
[TBL] [Abstract][Full Text] [Related]
13. Mast cell leukaemia progressed from myelodysplastic syndrome after acquiring KIT mutation.
Xu K; Childerhouse A; Gupta R
Int J Lab Hematol; 2024 Apr; 46(2):212-213. PubMed ID: 37723128
[No Abstract] [Full Text] [Related]
14. From the observation of atypical cells on blood smear to the diagnosis of mast cell leukemia: a case report in a 79 year old woman consulting for anemia.
Decker J; Meyer S; Latger-Cannard V; Visanica S; Loppinet E; Lesesve JF; Bénet B
Ann Biol Clin (Paris); 2017 Dec; 75(6):689-694. PubMed ID: 29043985
[TBL] [Abstract][Full Text] [Related]
15. Myelomastocytic leukemia versus mast cell leukemia versus systemic mastocytosis associated with acute myeloid leukemia: a diagnostic challenge.
Arredondo AR; Gotlib J; Shier L; Medeiros B; Wong K; Cherry A; Corless C; Arber DA; Valent P; George TI
Am J Hematol; 2010 Aug; 85(8):600-6. PubMed ID: 20658589
[No Abstract] [Full Text] [Related]
16. Chronic mast cell leukemia (MCL) with KIT S476I: a rare entity defined by leukemic expansion of mature mast cells and absence of organ damage.
Valent P; Berger J; Cerny-Reiterer S; Peter B; Eisenwort G; Hoermann G; Müllauer L; Mannhalter C; Steurer M; Bettelheim P; Horny HP; Arock M
Ann Hematol; 2015 Feb; 94(2):223-31. PubMed ID: 25209843
[TBL] [Abstract][Full Text] [Related]
17. Activating mutations of the c-kit proto-oncogene in a human mast cell leukemia cell line.
Kanakura Y; Furitsu T; Tsujimura T; Butterfield JH; Ashman LK; Ikeda H; Kitayama H; Kanayama Y; Matsuzawa Y; Kitamura Y
Leukemia; 1994 Apr; 8 Suppl 1():S18-22. PubMed ID: 7512180
[TBL] [Abstract][Full Text] [Related]
18. [Aleukemic mast cell leukemia (formerly: "malignant mastocytosis"): an extremely rare form of leukemia. A case report and simultaneously a contribution to revised classification of mastocytosis].
Horny HP; Krokowski M; Feller AC; Hintze G; Sotlar K; Valent P
Wien Klin Wochenschr; 2002 Mar; 114(5-6):222-8. PubMed ID: 12238313
[TBL] [Abstract][Full Text] [Related]
19. Mastocytosis: state of the art.
Horny HP; Sotlar K; Valent P
Pathobiology; 2007; 74(2):121-32. PubMed ID: 17587883
[TBL] [Abstract][Full Text] [Related]
20. Chronic mast cell leukaemia with exon 9
Manthri S; Costello PN; Krishnan K
BMJ Case Rep; 2020 Aug; 13(8):. PubMed ID: 32843387
[No Abstract] [Full Text] [Related]
[Next] [New Search]
